Literature DB >> 24433551

Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.

Thomas Moore1, Julia Kennedy, Suzanne McCarthy.   

Abstract

OBJECTIVE: To explore the General Practitioner (GP)-pharmacist relationship, to gain insight into communication between the professions and evaluate opinion on extension of the role of the community pharmacist.
METHODS: A postal questionnaire sent to 500 GPs and 335 community pharmacists with work addresses in the counties of Cork, Kerry, Tipperary, Waterford and Limerick, Ireland. KEY
FINDINGS: An overall response rate of 56% was achieved. Clear differences of opinion exist between GPs and pharmacists on the extension of the role of the community pharmacist; pharmacist provision of vaccinations (12% of GPs in favour versus 78% of pharmacists), pharmacists prescribing the oral contraceptive pill (18% GP versus 88% pharmacist) and increasing the prescribing power of the pharmacist (37% GP versus 95% pharmacist). Fifty-four percent of GPs and 97% of pharmacists were in favour of pharmacists providing screening services, while 82% of GPs and 96% of pharmacists were in favour of pharmacists dealing with minor ailments. Seventy-three percent of GPs and 43% of pharmacists agreed that communication between the professions was very good. DISCUSSION: This study identifies a clear difference of opinion on the extension of the role of the community pharmacist and recognises problems in communication between the professions. This comes on the background of continued calls from the Pharmaceutical Society of Ireland for an extension of pharmacist roles and continued opposition from the Irish Medical Organisation to such moves. This study highlights the need for increased dialogue between representative organisations and a commitment for professional agendas to be set aside in the best interests of patients.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  clinical pharmacy; clinical practice; delivery of care; primary care

Mesh:

Year:  2014        PMID: 24433551     DOI: 10.1111/ijpp.12084

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  7 in total

1.  Perspectives of practising pharmacists towards interprofessional education and collaborative practice in Qatar.

Authors:  Alla El-Awaisi; Maguy Saffouh El Hajj; Sundari Joseph; Lesley Diack
Journal:  Int J Clin Pharm       Date:  2018-07-26

2.  Stakeholders' views and experiences of pharmacist prescribing: a systematic review.

Authors:  Tesnime Jebara; Scott Cunningham; Katie MacLure; Ahmed Awaisu; Abdulrouf Pallivalapila; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

3.  Perceptions, Expectations, and Experience of Physicians About Pharmacists and Pharmaceutical Care Services in Pakistan: Findings and Implications.

Authors:  Khezar Hayat; Zia Ul Mustafa; Brain Godman; Muhammad Arshed; Jiaxing Zhang; Faiz Ullah Khan; Fahad Saleem; Krizzia Lambojon; Pengchao Li; Zhitong Feng; Yu Fang
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

4.  The alarming reality of medication error: a patient case and review of Pennsylvania and National data.

Authors:  Brianna A da Silva; Mahesh Krishnamurthy
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-09-07

5.  Development and validation of an instrument designed to measure factors influencing physician prescribing decisions.

Authors:  Mohsen Ali Murshid; Zurina Mohaidin; Mohammad Zayed
Journal:  Pharm Pract (Granada)       Date:  2019-12-14

6.  "Vaccination needs to be easy for the people, right ?": a qualitative study of the roles of physicians and pharmacists regarding vaccination in Switzerland.

Authors:  Michael J Deml; Philip E Tarr; Meliha Jusufoska; Marta Abreu de Azevedo; Josipa Tolic
Journal:  BMJ Open       Date:  2021-12-17       Impact factor: 2.692

7.  Co-designing a community pharmacy pharmacogenomics testing service in the UK.

Authors:  Tim Rendell; Julie Barnett; David Wright
Journal:  BMC Health Serv Res       Date:  2022-03-22       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.